financetom
Business
financetom
/
Business
/
Vanda Pharmaceuticals Gets Acquisition Proposal From Future Pak; Shares Rise Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vanda Pharmaceuticals Gets Acquisition Proposal From Future Pak; Shares Rise Pre-Bell
Apr 17, 2024 7:40 AM

07:30 AM EDT, 04/17/2024 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) has received three proposals from Future Pak, wherein the latter will acquire all of Vanda's shares -- the latest offer being at $7.25 to $7.75 per share, Future Pak said Wednesday.

Shares of Vanda rose more than 28% in recent Wednesday premarket activity.

Future Pak said it expressed to Vanda's board willingness to explore various ways to improve its proposal, "whether through structural enhancements, such as contingent value rights, or a potential increase in cash consideration," but the pharmaceutical firm has yet to engage with Future Pak.

Vanda did not immediately respond to a request for comment from MT Newswires.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
QVC Group Q3 revenue down on lower shipping units
QVC Group Q3 revenue down on lower shipping units
Nov 5, 2025
Overview * QVC Group ( QVCGA ) Q3 revenue decreased 6% yr/yr, driven by declines in QxH and Cornerstone * Operating income fell 61% yr/yr, pressured by tariffs and revenue decline * Adjusted OIBDA decreased 32% yr/yr due to higher marketing costs and sales deleverage Result Drivers * QxH REVENUE DECLINE - Driven by a 7% decrease in units shipped...
Teva Pharmaceutical Industries Q3 Non-GAAP Earnings, Revenue Rise; Updates 2025 Guidance
Teva Pharmaceutical Industries Q3 Non-GAAP Earnings, Revenue Rise; Updates 2025 Guidance
Nov 5, 2025
07:38 AM EST, 11/05/2025 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) reported Q3 non-GAAP earnings Wednesday of $0.78 per diluted share, up from $0.69 a year earlier. Analysts surveyed by FactSet expected $0.68. Net revenue for the quarter ended Sept. 30 was $4.48 billion, up from $4.33 billion a year earlier. Analysts surveyed by FactSet expected $4.34 billion....
Payoneer Q3 revenue beats estimates
Payoneer Q3 revenue beats estimates
Nov 5, 2025
Overview * Payoneer Q3 revenue of $270.9 mln beats analyst expectations * Revenue excluding interest income grew 15% yr/yr, driven by 9% volume growth * Net income for Q3 fell 66% yr/yr to $14.1 mln * Company repurchased $45 mln shares, totaling $94 mln year-to-date Outlook * Payoneer raises 2025 revenue guidance to $1,050 mln - $1,070 mln * Company...
Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast
Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast
Nov 5, 2025
Nov 5 (Reuters) - Cencora ( COR ) will invest over $1 billion through 2030 to expand its U.S. network, the drug distributor said on Wednesday, after forecasting adjusted profit for next year above Wall Street expectations. The company said it will build a second national distribution center in Harrison, Ohio, and new or enlarged sites in California and Alabama....
Copyright 2023-2026 - www.financetom.com All Rights Reserved